Virtus Fund Advisers’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Virtus Fund Advisers’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$350K	Buy	+17,647	New	+$379K	﹤0.01%	401

Other funds holding GTHX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Virtus Fund Advisers's GTHX Position: Q4 2017 in Review

Virtus Fund Advisers opened a new position in G1 Therapeutics, Inc. Common Stock (GTHX) in Q4 2017: 17,647 shares worth $350K. The stake represents ﹤0.01% of the portfolio and ranks #401 among its holdings.

57 funds tracked by Wall St. Rank hold GTHX as of Q4 2017.

Virtus Fund Advisers held 17,647 shares of G1 Therapeutics, Inc. Common Stock worth $350K as of Q4 2017.
G1 Therapeutics, Inc. Common Stock was a new Virtus Fund Advisers position in Q4 2017.
G1 Therapeutics, Inc. Common Stock made up ﹤0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #401 holding.
57 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.